Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab maintenance therapy in moderately to severely active ulcerative colitis
2006-003399-37Phase 3Completed
- Sponsor
- Janssen Biologics B.V.
- Start
- Jul 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Golimumab maintenance with Placebo maintenance (2 arms). Primary endpoint: Clinical response through Week 54. Started Jul 2007; status: completed.
02
Drugs
golimumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-003399-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003399-37.